Product image of Zemplar (Paricalcitol) supplied by GNH India

Zemplar

Active Ingredient:
Paricalcitol
Origin:
EU

Zemplar (Paricalcitol)

Paricalcitol (Zemplar) is a vitamin D analog prescribed to manage secondary hyperparathyroidism in adults undergoing haemodialysis. This prescription-only medication helps regulate calcium and phosphorus levels. Suitable for intravenous use during dialysis sessions. Always follow healthcare provider guidance when using this treatment.

Manufacturer / TM Owner

Abbvie S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Paricalcitol is used to treat secondary hyperparathyroidism in adults receiving haemodialysis. It works by reducing elevated parathyroid hormone levels, which can impact bone health. This medication is specifically formulated for patients with chronic kidney disease requiring dialysis. It is not intended for conditions unrelated to secondary hyperparathyroidism.

Side Effects

  • Paricalcitol may help restore balance to calcium and phosphorus levels in the body. Patients often notice improved bone health markers over time with consistent use. Some individuals report reduced muscle weakness or bone pain as secondary benefits. Effects vary based on individual health conditions and treatment adherence.

Precautions & Warnings

  • Store paricalcitol at controlled room temperature, away from moisture and direct light. Keep this medication out of reach of children and pets. Always use as directed by a healthcare professional. Report any unusual symptoms to your doctor promptly. Do not adjust dosage without medical supervision.

Avoid Interactions

  • Paricalcitol may interact with other medications affecting calcium or vitamin D metabolism. Caution is advised when using phosphate binders, calcium supplements, or CYP3A inhibitors. Grapefruit products may alter how the body processes paricalcitol. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Paricalcitol is used to treat secondary hyperparathyroidism in adults undergoing haemodialysis.

Paricalcitol is given as an intravenous injection during haemodialysis sessions.

Paricalcitol is specifically approved for secondary hyperparathyroidism in dialysis patients.

Inform your doctor about all medications, supplements, and medical conditions before starting paricalcitol.

Some patients may experience nausea, vomiting, or mild dizziness while using paricalcitol.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Paricalcitol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT